Gastric Cancer with Peritoneal Metastasis

• CLINICAL_TRIALS research · 2026-02-18
  Clinical Trial Update: Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis [Phase 2]

  Phase 2 clinical trial evaluating Cadonilimab, LM-302, and S-1 with intraperitoneal paclitaxel for Claudin 18.2-positive gastric cancer with…

• CLINICAL_TRIALS research · 2025-06-22
  Clinical Trial Update: An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II [Phase 2, Phase 3]

  An open prospective randomized trial evaluating intraperitoneal Prospidelong gel for gastric cancer with peritoneal dissemination; Phase 2/3…

• CLINICAL_TRIALS trial_result · 2023-08-08
  Clinical Trial Update: A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis [Phase 1, Phase 2]

  Phase Ib/II clinical trial evaluating Cytoreductive Surgery with hyperthermic intraperitoneal chemotherapy and post-operative intraperitonea…